Fulgent Genetics, Inc.

NasdaqGM:FLGT Voorraadrapport

Marktkapitalisatie: US$546.6m

Fulgent Genetics Toekomstige groei

Future criteriumcontroles 1/6

Fulgent Genetics zal naar verwachting groeien in winst en omzet met respectievelijk 43.5% en 12.7% per jaar. De winst per aandeel zal naar verwachting groeien met 34.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -0.8% zijn.

Belangrijke informatie

43.5%

Groei van de winst

34.6%

Groei van de winst per aandeel

Healthcare winstgroei20.9%
Inkomstengroei12.7%
Toekomstig rendement op eigen vermogen-0.8%
Dekking van analisten

Low

Laatst bijgewerkt11 Nov 2024

Recente toekomstige groei-updates

Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

May 07
Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

Recent updates

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Sep 25

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Sep 09

Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio

Jul 17
Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio

Fulgent Genetics: Growth Is Returning

Jun 06

Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package

May 10
Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package

Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

May 07
Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?

Mar 01
Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?

Fulgent Genetics: Buy Growth Ahead Below Liquidation Value

Feb 21

Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price

Jan 17
Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price

Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?

Dec 14
Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?

Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?

Aug 09
Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?

Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

May 09
Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report

Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital

Apr 19
Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital

Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Jan 15
Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)

Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

Dec 28
Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?

What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates

Nov 16
What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates

Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

Oct 27
Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching

Wait For Fulgent Genetics To Grow Up

Oct 13

We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending

Sep 19
We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending

Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly

Sep 05
Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly

Fulgent Genetics: Poised To Survive Its Post-Covid Hangover

Jul 26

Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement

Jul 21
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement

Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency

Jun 04
Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency

Fulgent Is Putting Its Cash Bonanza To Work

May 15

These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

May 04
These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely

Fulgent Genetics: Now The Going Could Get Much Tougher

Apr 10

Fulgent Genetics: COVID Bolstered The Underlying Business

Mar 17

Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business

Feb 27

Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy

Feb 09

Fulgent Genetics: Sell Volatility

Jan 26

Winst- en omzetgroeiprognoses

NasdaqGM:FLGT - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026365-48N/AN/A3
12/31/2025324-55N/AN/A3
12/31/2024282-52N/AN/A3
9/30/2024278-165-2911N/A
6/30/2024291-1631237N/A
3/31/2024288-1661842N/A
12/31/2023289-168527N/A
9/30/2023286-642145N/A
6/30/2023307-493156N/A
3/31/2023365-264257N/A
12/31/2022619143235254N/A
9/30/2022803272277297N/A
6/30/2022925392411429N/A
3/31/2022953461476494N/A
12/31/2021993507515539N/A
9/30/20211,036569554596N/A
6/30/2021910493405453N/A
3/31/2021773417327372N/A
12/31/2020422214105141N/A
9/30/202013548-66N/A
6/30/2020443-11N/A
3/31/202035046N/A
12/31/201933046N/A
9/30/201930-266N/A
6/30/201925-412N/A
3/31/201922-602N/A
12/31/201821-6-4-1N/A
9/30/201820-5-7-3N/A
6/30/201819-6N/A-2N/A
3/31/201818-5N/A-1N/A
12/31/201719-3N/A1N/A
9/30/2017200N/A4N/A
6/30/201721-5N/A4N/A
3/31/201720-13N/A5N/A
12/31/201618-14N/A4N/A
9/30/201615-22N/A3N/A
6/30/201613-15N/A2N/A
3/31/201611-6N/A0N/A
12/31/201510-5N/A-1N/A
12/31/20141-1N/A-4N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat FLGT de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat FLGT de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat FLGT de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van FLGT ( 12.7% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van FLGT ( 12.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Er wordt voorspeld dat FLGT binnen 3 jaar verliesgevend zal zijn.


Ontdek groeibedrijven